Natco Pharma’s Stock Crashes 20% After Q3 Earnings – Big Blow or Buying Opportunity??

Natco Pharma Declares 75% Dividend After Strong Q2 Earnings Despite market volatility, Natco Pharma rewarded its shareholders by announcing a 75% interim dividend following a robust 83% jump in net… Read more